Cargando…
HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model
Development of chronic lymphocytic leukemia (CLL) is associated with severe immune dysfunction. T-cell exhaustion, immune checkpoint upregulation, and increase of regulatory T cells contribute to an immunosuppressive tumor microenvironment. As a result, CLL patients are severely susceptible to infec...
Autores principales: | Maharaj, Kamira, Powers, John J., Mediavilla-Varela, Melanie, Achille, Alex, Gamal, Wael, Quayle, Steven, Jones, Simon S., Sahakian, Eva, Pinilla-Ibarz, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719839/ https://www.ncbi.nlm.nih.gov/pubmed/33329575 http://dx.doi.org/10.3389/fimmu.2020.590072 |
Ejemplares similares
-
Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies
por: Maharaj, Kamira, et al.
Publicado: (2022) -
The role of Th17 cells in chronic lymphocytic leukemia: friend or foe?
por: Gamal, Wael, et al.
Publicado: (2022) -
CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness
por: Lewis, Richard, et al.
Publicado: (2021) -
p53-independent ibrutinib responses in an Eμ-TCL1 mouse model demonstrates efficacy in high-risk CLL
por: Lee, H J, et al.
Publicado: (2016) -
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells
por: Knox, Tessa, et al.
Publicado: (2019)